-
-
-
-
-
-
-
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
-
-
-
-
-
-
-
Jefferies Sees Amylin's (AMLN) Bydureon Receiving FDA Approval Following Positive QT Study Results
-
-
-
-
-
-
-
Jefferies & Co Maintains a 'Buy' on Amylin Pharmaceuticals (AMLN); Raises PT
-
-
-
-
-
-
-
Pre-Open Movers 06/09: Hilb Rogal & Hobbs (HRH) Surges on Buy, Lehman (LEH) Weak After Massive Loss/Capital Raise
-
56,405 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All